Disruption of the interaction of PHB1 with AMPK induced by RX-375 resulted in activation of AMPK, reducing inflammation and hepatic steatosis in obese mice (Kanagaki et al., 2023) (Figure 3). Here, PRKAA2 is linked to fatty liver disease.